Notice of Intent to Sole Source - SSR Health US Prescription Pricing Data Annual Subscription

Closed Special Notice Posted

Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Washington, District of Columbia 20201, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Health and Human Services (HHS) has published a Special Notice indicating its intent to sole source a contract for access to SSR Health's proprietary US prescription brand drug pricing data, including estimates of net pricing after rebates. This data is needed to validate the prescription drug data being collected from plan sponsors, issuers, and pharmacy benefit managers under the No Surprises Act.

The purpose of this Special Notice is to inform the public that HHS has determined that SSR Health is the only responsible source for this specific data, as its methodology is proprietary. The proposed contract includes a base period of 09/11/2024 - 09/10/2025 with four one-year option periods, for a total potential period of performance through 09/10/2029. The total estimated value, including all options, is undisclosed. HHS has stated that if a follow-on competitive contract is needed in FY 2029, it will pursue that at that time. There are no set-aside requirements, and the deadline for responses is April 24, 2024.

Notice text

SSR Health's proprietary data is the only commercially available source of estimated prescription drug rebates that we have identified.

Files

Similar open opportunities

Opportunity Agency Set-aside Responses due
Notice of Intent to award sole source - Compact Robotic Prescription Dispensing System - Tsaile Health Center Tsaile, Arizona 86556, United States · NAICS 339112 Indian Health Service No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors